Polyclonal Rabbit anti‑Human BUB1B / BubR1 Antibody (310‑390 aa, Internal, WB) LS‑C382344
Polyclonal Rabbit anti‑Human BUB1B / BubR1 Antibody (310‑390 aa, Internal, WB) LS‑C382344
Antibody:
BUB1B / BubR1 Rabbit anti-Human Polyclonal (310-390 aa, Internal) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
BUB1B / BubR1 Rabbit anti-Human Polyclonal (310-390 aa, Internal) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
BubR1 antibody LS-C382344 is an unconjugated rabbit polyclonal antibody to BubR1 (BUB1B) (310-390 aa, Internal) from human. It is reactive with human and mouse. Validated for ELISA and WB.
Target
Human BUB1B / BubR1
Synonyms
BUB1B | Bub1A | BUBR1 | HBUBR1 | Protein SSK1 | SSK1 | BUB1beta | MAD3L
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human BubR1
Epitope
310-390 aa, Internal
Specificity
BubR1 Polyclonal Antibody detects endogenous levels of BubR1 protein.
Applications
- Western blot (1:500 - 1:2000)
- ELISA (1:20000)
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA, Proximity Ligation Assay, RNA interference
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human, Mouse
Applications:
Immunofluorescence, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, Flow Cytometry
Species:
Human, Monkey, Rat, Dog
Applications:
Immunofluorescence, Western blot, Flow Cytometry
Reactivity:
Human
Range:
7.8-500 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/26/2024